BioAmber Inc. filed a motion in the US Bankruptcy Court seeking the dismissal of its Chapter 11 bankruptcy case on May 30, 2018. Motion was filed on the basis that, that the time and expense of the Chapter 11 Case is unnecessary and that a more efficient and effective approach is to administer the totality of the Debtor’s insolvency proceedings in Canada and to have such proceeding recognized as the foreign main proceeding under chapter 15 of the Bankruptcy Code.